rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    IXJ
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Defensive healthcare ETFs: broad funds, income options, and key caveats

      Investing.com -- Healthcare often acts as a shelter because people keep buying medicine and care in any economy. The screener (snapshot data, which may lag live prices) points to a few broad, low-cost US funds. Nasdaq-100 funds like Invesco QQQ Trust (QQQ) fell about 9% over 3 months. Healthcare funds gained roughly 10-12% over the same period.

      Nov 9Yahoo FinanceIHFIXJIYH
      The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power? | The Motley Fool

      PJP delivered 32.8% returns over one year with concentrated U.S. pharma exposure, while IXJ offers broader global healthcare diversification and a higher dividend yield.

      Nov 7The Motley FoolIXJ
      Which Healthcare ETF Is the Better Buy: iShares’ Global IXJ or First Trust’s Biotech FBT? | The Motley Fool

      IXJ offers diversified global exposure at lower cost, while FBT concentrates on biotech with higher volatility and stronger recent returns.

      Oct 26The Motley FoolFBTIXJ
      IYH Beats IXJ on Returns While Global Fund Offers Higher Yield | The Motley Fool

      U.S. healthcare stocks delivered 28.8% gains over one year versus 22.5% for international peers. Both funds carry nearly identical expense ratios and low volatility profiles.

      Oct 6The Motley FoolIXJIYH
      IXJ: Healthcare Sector Dashboard For September (NYSEARCA:IXJ)
      Sep 17Seeking AlphaIXJ
      Does Fidelity or iShares Have the Better Healthcare ETF For Investors Seeking Broad Exposure? | The Motley Fool

      FHLC delivered 24% returns over one year with a 0.08% expense ratio, while IXJ offers global diversification but trails on performance and costs more to own.

      Sep 16The Motley FoolFHLCIXJ
      State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors | The Motley Fool

      XLV's 0.08% expense ratio and 22.7% 1-year return outpace IXJ's global reach, but international diversification comes at a cost.

      Sep 13The Motley FoolIXJ
      IXJ vs XPH: Global Healthcare ETF or Pharma Focus? | The Motley Fool

      XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.

      Sep 12The Motley FoolIXJXPH
      IXJ vs XPH: Global Healthcare ETF or Pharma Focus?
      Sep 11Yahoo FinanceIXJ
      Which Healthcare ETF Is the Better Buy: Vanguard's VHT or iShares' IXJ? | The Motley Fool

      VHT charges low fees and holds more than 400 stocks for broader diversification. IXJ's portfolio of 110 holdings includes international exposure -- but comes at a higher cost.

      Aug 25The Motley FoolIXJ

      This is the newest page. Registered accounts read further back.